Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Basilea signs antibiotic deal with J&J; terminated

Executive Summary

Basilea Pharmaceutica AG (Swiss company focused on dermatology and infectious disease therapeutics) has granted Johnson & Johnson's Cilag AG division an exclusive worldwide development, manufacturing, and marketing license to its ceftobiprole (also known as BAL5788).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Co-Promotion

Related Companies

UsernamePublicRestriction

Register